Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | CAPSULE;ORAL | 150MG | 0 | RIFAMPIN | RIFAMPIN |
002 | CAPSULE;ORAL | 300MG | 0 | RIFAMPIN | RIFAMPIN |
FDA Submissions
| ORIG | 1 | AP | 2013-08-21 | |
LABELING; Labeling | SUPPL | 8 | AP | 2020-03-31 | STANDARD |
LABELING; Labeling | SUPPL | 9 | AP | 2020-03-31 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2020-03-31 | STANDARD |
LABELING; Labeling | SUPPL | 11 | AP | 2020-03-31 | STANDARD |
LABELING; Labeling | SUPPL | 12 | AP | 2020-03-31 | STANDARD |
LABELING; Labeling | SUPPL | 13 | AP | 2020-08-17 | STANDARD |
LABELING; Labeling | SUPPL | 15 | AP | 2021-09-14 | STANDARD |
LABELING; Labeling | SUPPL | 17 | AP | 2022-08-30 | STANDARD |
LABELING; Labeling | SUPPL | 18 | AP | 2022-08-30 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 8 | Null | 7 |
SUPPL | 9 | Null | 7 |
SUPPL | 10 | Null | 15 |
SUPPL | 11 | Null | 15 |
SUPPL | 12 | Null | 15 |
SUPPL | 13 | Null | 7 |
SUPPL | 15 | Null | 15 |
SUPPL | 17 | Null | 15 |
SUPPL | 18 | Null | 7 |
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
CDER Filings
LUPIN PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 90034
[companyName] => LUPIN PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"RIFAMPIN","activeIngredients":"RIFAMPIN","strength":"150MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"RIFAMPIN","activeIngredients":"RIFAMPIN","strength":"300MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
[labels] =>
[originalApprovals] => [{"actionDate":"RIFAMPIN","submission":"RIFAMPIN","actionType":"150MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"RIFAMPIN","submission":"RIFAMPIN","actionType":"300MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)